Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Plast Reconstr Surg Glob Open ; 7(9): e2407, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31942386

ABSTRACT

Little has been published about dressing the breast after surgery and the potential benefits of added support to the routine use of a nonwired bra postoperatively. We report a postsurgical breast taping method and suggest its use might help reduce minor postsurgical complications and subsequent impaired scarring.

2.
Lasers Med Sci ; 29(1): 225-30, 2014 Jan.
Article in English | MEDLINE | ID: mdl-23609559

ABSTRACT

Reflectance spectroscopy can be used to quantitate subtle differences in color. We applied a portable reflectance spectrometer to determine its utility in the evaluation of pulsed dye laser treatment of port wine stains (PWS) and in prediction of clinical outcome, in a prospective study. Forty-eight patients with PWS underwent one to nine pulsed dye laser treatments. Patient age and skin color as well as PWS surface area, anatomic location, and color were recorded. Pretreatment spectrophotometric measurements were performed. The subjective clinical results of treatment and the quantitative spectrophotometry results were evaluated by two independent teams, and the findings were correlated. The impact of the clinical characteristics on the response to treatment was assessed as well. Patients with excellent to good clinical results of laser treatments had pretreatment spectrophotometric measurements which differed by more than 10%, whereas patients with fair to poor results had spectrophotometric measurements with a difference of of less than 10%. The correlation between the spectrophotometric results and the clinical outcome was 73% (p < 0.01). The impact of the other clinical variables on outcome agreed with the findings in the literature. Spectrophotometry has a higher correlation with clinical outcome and a better predictive value than other nonmeasurable, nonquantitative, dependent variables.


Subject(s)
Lasers, Dye/therapeutic use , Port-Wine Stain/pathology , Port-Wine Stain/surgery , Skin Pigmentation , Spectrophotometry/methods , Adolescent , Child , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Male , Optical Phenomena , Port-Wine Stain/physiopathology , Prospective Studies , Treatment Failure , Treatment Outcome , Young Adult
4.
Dermatol Surg ; 34(4): 501-7, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18261101

ABSTRACT

BACKGROUND: The integrity of each of the components of the auricle is important for its overall aesthetic appearance. Cartilage-exposing nonhelical defects that are too large to be closed primarily without distorting the auricle may be reconstructed with local flaps. OBJECTIVE: The objective was to present our experience with the reconstruction of nonhelical medium-sized defects using a variety of simple, one-stage local flaps. PATIENTS AND METHODS: Eighteen patients who underwent reconstruction of nonhelical auricular defects with local flaps at our center from 2003 to 2006. Defect size ranged from about 10 to 20 mm. Various methods were used for reconstruction as follows: conchal defect (n=11)--pull-through postauricular flap or cutaneous rotation flap from the concha itself; triangular fossa defect (n=3)--transposition-rotation flap from the concha or cutaneous periauricular pull-through flap via the root of the helix; antihelical defect (n=2)--V-Y advancement flap from the skin of the antihelix; and tragus defect (n=2)--periauricular cutaneous flap. RESULTS: All flaps survived. Transient congestion was noted in four patients. The aesthetic results were good, with no auricular deformation. CONCLUSION: It is important that reconstructive surgeons be familiar with a variety of basic flaps for reconstruction of nonhelical defects. An algorithm for nonhelical flap reconstruction is suggested.


Subject(s)
Ear Auricle , Ear Deformities, Acquired/surgery , Plastic Surgery Procedures , Surgical Flaps , Suture Techniques , Carcinoma/pathology , Carcinoma/surgery , Cohort Studies , Ear Deformities, Acquired/etiology , Ear Deformities, Acquired/pathology , Ear Neoplasms/pathology , Ear Neoplasms/surgery , Humans , Skin Neoplasms/pathology , Skin Neoplasms/surgery
7.
Dermatol Surg ; 32(9): 1147-50, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16970695

ABSTRACT

BACKGROUND: Angiokeratomas of Fordyce are typically asymptomatic vascular lesions characterized by blue-to-red papules with a scale surface, most often located on the scrotum. Although considered benign, the lesions may bleed, either spontaneously or secondary to rupture, leading to patient anxiety and social embarrassment. OBJECTIVE: The objective was to determine the safety and effectiveness of 585-nm pulsed dye laser for the treatment of angiokeratomas of Fordyce. METHODS: Twelve patients with Fitzpatrick skin type II to IV were treated for angiokeratomas of Fordyce with pulsed dye laser (5.5-8.0 J/cm(2)) in two to six sessions. Lesion clearance was evaluated by two specialists on the basis of digital photographs taken before the first treatment and 2 months after the last treatment. RESULTS: Seven patients had an excellent response (clearance rating 75%-100%) and five patients had a good response (clearance rating 50%-75%). Transient purpura and pain were present in all patients. Bleeding during treatment occurred in five patients. There were no permanent side effects. CONCLUSION: Pulsed dye laser is effective and safe for the treatment of angiokeratoma of Fordyce, with minimum side effects, providing an additional nonablative therapeutic option.


Subject(s)
Angiokeratoma/radiotherapy , Genital Neoplasms, Male/radiotherapy , Low-Level Light Therapy/methods , Skin Neoplasms/radiotherapy , Adult , Aged , Angiokeratoma/pathology , Follow-Up Studies , Genital Neoplasms, Male/pathology , Humans , Male , Middle Aged , Penile Neoplasms/pathology , Penile Neoplasms/radiotherapy , Scrotum/pathology , Skin Neoplasms/pathology , Treatment Outcome
9.
Cancer ; 94(12): 3101-6, 2002 Jun 15.
Article in English | MEDLINE | ID: mdl-12115340

ABSTRACT

BACKGROUND: Ultrasonography has a limited value in endometrial assessment for identification of endometrial pathologies in postmenopausal tamoxifen-treated patients. METHODS: We compared the rate of endometrial pathologies and the mean +/- SD of endometrial thickness diagnosed after the first and second transvaginal ultrasonographic studies performed on 55 postmenopausal tamoxifen-treated patients with secondary endometrial thickening (Group I). This rate was also compared with 46 similar patients without secondary thickening (Group II). We also compared the mean +/- SD of endometrial thickness detected in various ultrasonographic studies, as well as various clinical features. RESULTS: A significantly higher rate of endometrial pathologies, including two cases of endometrial cancer identified in gynecologically asymptomatic patients (3.6%), was diagnosed in Group I after the second study compared with the first study (52.7% and 9.1%, respectively; P = 0.001) and compared with those diagnosed after the second study in Group II (30.4%; P = 0.03). There was a significant increase (74.7 +/- 115%) in endometrial thickness after the second study compared with the first study performed on Group I (10.7 +/- 5.53 mm and 16.59 +/- 5.53 mm, respectively; P = 0.0001) and a significant difference in endometrial thickness demonstrated in the second study performed on Groups I and II (16.59 +/- 5.53 mm and 11.4 +/- 3.91 mm, respectively; P = 0.001). There were no significant differences in the time elapsed since the diagnosis of breast carcinoma and from the beginning of tamoxifen treatment to the performance of the first ultrasonographic study as well as the time elapsed between the first and second studies performed. CONCLUSIONS: A significant increase (> 50%) in secondary endometrial thickening, measured ultrasonographically, in postmenopausal tamoxifen-treated patients, is associated with a high rate of endometrial pathologies, including endometrial cancer.


Subject(s)
Breast Neoplasms/drug therapy , Endometrium/diagnostic imaging , Estrogen Antagonists/therapeutic use , Tamoxifen/therapeutic use , Aged , Breast Neoplasms/pathology , Endometrium/pathology , Female , Humans , Middle Aged , Postmenopause , Ultrasonography
SELECTION OF CITATIONS
SEARCH DETAIL
...